A few days ago，Abbott announced that it will acquire the pharmaceutical department of the Belgian Solvay company for about $ 7.1 billion (about 4.8 billion euros)。This will increase the revenue of Abbott's pharmaceutical business by 18%，At the same time，Make it have more room for development in the global emerging pharmaceutical market。

      Solvay is the world's largest pure alkali producer，In 1983, we took the lead stake sports betting appin My stake betting applaunching modern antidepressants to the market。In Solvay's annual revenue，A considerable part of the car and construction industry，And these two industries are the most affected by the financial crisis。

      After the acquisition is complete，Solvay's pharmaceutical department will bring more than $ 3 billion in product revenue to Abbott each year，Three -quarters of which are from markets outside the United States。This will help improve the international status of Abbott in emerging markets (such as Eastern Europe and Asia)。It is reported，In addition to acquiring the pharmaceutical department of solving Solvay，Abbott is still stake betting appimplementing Stake Sports Bettingfurther mergers and acquisitions strategies。